Ivacaftor 25 mg/75 mg
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Vertex Pharmaceuticals Incorporated
Overview
Ivacaftor 25 mg/75 mg is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Ivacaftor 25 mg/75 mg clinical trials
Explore related
Medical disclaimer. This page summarizes research about Ivacaftor 25 mg/75 mg for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.